FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher O'Connor

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Audrey H Wu; Peter E Carson; Wayne C Levy; Alan B Miller; Gerald W Neuberg; Christopher M O'Connor; Kathleen B Welch; Jalal K Ghali
Association between bilirubin and mode of death in severe systolic heart failure.
Robert J Mentz; Christopher M O'Connor; Randall C Starling; Amanda L Stebbins; John R Teerlink; Dan Atar; Robert M Califf; Justin A Ezekowitz; G Michael Felker; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; Piotr Ponikowski
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
Robb D Kociol; Kerry L Lee; Steven E McNulty; Christopher M O'Connor; Margaret M Redfield; Russell P Tracy; Eugene Braunwald; G Michael Felker; Adrian F Hernandez
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher O'Connor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Audrey H Wu; Peter E Carson; Wayne C Levy; Alan B Miller; Gerald W Neuberg; Christopher M O'Connor; Kathleen B Welch; Jalal K Ghali
Association between bilirubin and mode of death in severe systolic heart failure.
The American journal of cardiology 2013;111(8):1192-7.
2013: Robert J Mentz; Christopher M O'Connor; Randall C Starling; Amanda L Stebbins; John R Teerlink; Dan Atar; Robert M Califf; Justin A Ezekowitz; G Michael Felker; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; Piotr Ponikowski
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
European journal of heart failure 2013;15(4):456-64.
2013: Robb D Kociol; Kerry L Lee; Steven E McNulty; Christopher M O'Connor; Margaret M Redfield; Russell P Tracy; Eugene Braunwald; G Michael Felker; Adrian F Hernandez
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Circulation. Heart failure 2013;6(2):240-5.
2013: David P Kao; JoAnn Lindenfeld; Alan B Miller; Guinevere A Murphy; Christopher M O'Connor; Jonathan F Plehn; Will Sauer; Marc A Silver; Michel White; Peter E Carson; Gordon Davis; Mona Fiuzat; Stephen S Gottlieb; Ryan Aleong; Inder S Anand; Michael R Bristow
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
European journal of heart failure 2013;15(3):324-33.
2013: Mona Fiuzat; William E Kraus; Megan L Neely; Kirkwood Adams; Mark Donahue; G Michael Felker; Ileana L Piña; Aijing Z Starr; David Whellan; Christopher M O'Connor
Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy.
European journal of heart failure 2013;15(3):258-66.
2013: Robert J Mentz; Karen Chiswell; Mona Fiuzat; Gregg C Fonarow; Daniel Wojdyla; Christopher M O'Connor
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
The American journal of cardiology 2013;111(4):582-7.
2013: Robert J Mentz; Ileana L Piña; Phillip J Schulte; David J Whellan; Stephen J Ellis; Mona Fiuzat; Jerome L Fleg; Steven J Keteyian; Dalane W Kitzman; William E Kraus; Christopher M O'Connor
Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
American heart journal 2013;165(2):193-9.
2013: Robert J Mentz; Christopher M O'Connor; Karl Swedberg; James E Udelson; Muthiah Vaduganathan; Faiez Zannad; Bradley D Allen; Andrew P Ambrosy; Robert O Bonow; Angela J Fought; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
European journal of heart failure 2013;15(1):61-8.
2012: Christopher M O'Connor; Tariq Ahmad
Can we prevent heart failure with exercise?
Journal of the American College of Cardiology 2012;60(24):2548-9.
2012: Robert J Mentz; Christopher M O'Connor; Peter S Pang; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Andrew P Ambrosy; Matthew J Chung; Mihai Gheorghiade; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
American heart journal 2012;164(6):884-92.e2.
2012: Steven J Keteyian; Dalane W Kitzman; William E Kraus; Eric S Leifer; Christopher M O'Connor; Ileana L Piña; David S Rendall; David Whellan; James A Blumenthal; Clinton A Brawner; Alain Cohen-Solal; Lawton S Cooper; Jerome L Fleg; Nancy Houston Miller
Relation between volume of exercise and clinical outcomes in patients with heart failure.
Journal of the American College of Cardiology 2012;60(19):1899-905.
2012: Glen L Xiong; Mona Fiuzat; Wei Jiang; Ranga Krishnan; Maragatha Kuchibhatla; Christopher M O'Connor
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
Circulation. Heart failure 2012;5(6):688-92.
2012: Faiez Zannad; George L Bakris; Johann Bauersachs; Farzin Beygui; Alain Cohen-Solal; Gerasimos S Filippatos; Wendy Gattis-Stough; Mihai Gheorghiade; Aldo P Maggioni; Ziad A Massy; John J V McMurray; Robert J Mentz; Christopher M O'Connor; Atul Pathak; Ileana L Piña; Patrick Rossignol; Luis M Ruilope; Hani N Sabbah; Domenic A Sica; Allan D Struthers; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Bertram Pitt
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
European heart journal 2012;33(22):2782-95.
2012: G Michael Felker; Gregg C Fonarow; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; John J V McMurray; Marco Metra; Stefan D Anker; Paul W Armstrong; Dan Atar; Javed Butler; Robert M Califf; Kenneth Dickstein; Randall C Starling; W H Wilson Tang; Richard W Troughton; Adriaan A Voors; Christopher M O'Connor
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
European journal of heart failure 2012;14(11):1257-64.
2012: Robert J Mentz; Angeles Alonso-Garcia; Gheorghe-Andrei Dan; Mona Fiuzat; Sidney Goldstein; Juan-Carlos Kaski; Felipe A Martinez; Bertram Pitt; Luis M Ruilope; Norman Stockbridge; Faiez Zannad; Christopher M O'Connor
Implications of geographical variation on clinical outcomes of cardiovascular trials.
American heart journal 2012;164(3):303-12.
2012: Mona Fiuzat; Jerome Fleg; Steven J Keteyian; Dalane Kitzman; William E Kraus; Ileana L Piña; David Whellan; Daniel Wojdyla; Christopher M O'Connor
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.
Journal of the American College of Cardiology 2012;60(3):208-15.
2012: Afshin Farzaneh-Far; Mona Fiuzat; Christopher M O'Connor; Harry R Phillips; Ashwani Sastry; Leslee J Shaw; Linda K Shaw; Aijing Z Starr; Salvador Borges-Neto
Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
JACC. Cardiovascular imaging 2012;5(7):715-24.
2012: Robert J Mentz; Christopher M O'Connor; Philip H Schmidt; Karl Swedberg; Faiez Zannad; Andrew P Ambrosy; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
Journal of cardiac failure 2012;18(7):515-23.
2012: Julie Adams; Jude D Alexander; Robert M Califf; Eric J Christopher; Greg L Clary; Michael S Cuffe; Ranga R Krishnan; Maragatha Kuchibhatla; Christopher M O'Connor; Wei Jiang
Association of depression and survival in patients with chronic heart failure over 12 Years.
Psychosomatics 2012;53(4):339-46.
2012: Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Daniel Wojdyla; Robert J Mentz; Marco Metra; Karen Chiswell; John G Cleland; Gad Cotter; Beth A Davison; Mona Fiuzat; Michael M Givertz; George A Mansoor; Barry M Massie
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.
European journal of heart failure 2012;14(6):605-12.
2012: Robert J Mentz; Mona Fiuzat; Monica Kraft; Joann Lindenfeld; Christopher M O'Connor
Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?
Journal of cardiac failure 2012;18(5):413-22.
2012: Robert J Mentz; Salvador Borges-Neto; G Michael Felker; Mona Fiuzat; Harry R Phillips; Linda K Shaw; Christopher M O'Connor
Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease).
The American journal of cardiology 2012;109(9):1272-7.
2012: Robert J Mentz; Daniel M Wojdyla; Karen Chiswell; Mona Fiuzat; Gregg C Fonarow; Mihai Gheorghiade; Christopher M O'Connor
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
European journal of heart failure 2012;14(4):395-403.
2012: John R Teerlink; Scott Thomson; Paul D Varosy; Adriaan A Voors; Denise Wolko; Michael R Zile; Marco Metra; Alan B Miller; Jay P Mohr; Christopher M O'Connor; Ileana L Piña; Piotr Ponikowski; Christina M Salerno; Peter E Carson; John G F Cleland; Gad Cotter; Beth A Davison; Paul Delucca; Howard Dittrich; Michael M Givertz; Paul J Hauptman; Vicente J Iragui; David H Lovett; George A Mansoor; Barry M Massie
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(3):233-44.
2012: Gregg C Fonarow; Mihai Gheorghiade; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary N Walsh; Nancy M Albert; Anne B Curtis; Clyde W Yancy
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.
Journal of the American Heart Association 2012;1(1):16-26.
2012: Eric J Velazquez; Judson B Williams; Eric Yow; Kerry L Lee; Christopher M O'Connor; Harry R Phillips; Linda K Shaw; Peter K Smith; Robert H Jones
Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy.
The Annals of thoracic surgery 2012;93(2):523-30.
2012: Sandesh Dev; G Michael Felker; Patricia A Adams; Joseph G Rogers; Linda K Shaw; Shailesh C Shirolkar; Susanna R Stevens; Christopher M O'Connor
Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure.
Cardiology 2012;123(3):145-53.
2012: Christopher M O'Connor; Jonathan F Plehn; J David Port; Alastair D Robertson; Marc A Silver; Ryan Walsh; Michel White; William T Abraham; Inder S Anand; James Carr; Peter E Carson; Gordon Davis; Mona Fiuzat; Stephen S Gottlieb; Laura C Lazzeroni; Stephen B Liggett; JoAnn Lindenfeld; Allen Medway; Alan B Miller; Guinevere A Murphy; Penny Nelson; Michael R Bristow
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
PloS one 2012;7(10):e44324.
2012: Mihai Gheorghiade; Patches Johnson Inge; Mark L McBride; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; J Thomas Heywood; Mary Norine Walsh; Clyde W Yancy; Nancy M Albert; Anne B Curtis; Gregg C Fonarow
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.
Congestive heart failure (Greenwich, Conn.) 2012;18(1):9-17.
2012: Christopher M O'Connor; Ileana L Piña; David Rendall; David Whellan; Daniel Wojdyla; Faiez Zannad; Eric Leifer; Robert M Clare; Lawton S Cooper; Stephen J Ellis; Lawrence J Fine; Mona Fiuzat; Jerome L Fleg; Steven J Keteyian; Dalane W Kitzman; William E Kraus; Kerry L Lee
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.
Circulation. Heart failure 2012;5(1):63-71.
2012: G Michael Felker; Mona Fiuzat; Dalane W Kitzman; Ileana L Piña; Linda K Shaw; Shailesh C Shirolkar; David Whellan; Faiez Zannad; Luca Bettari; Robert Clare; Mark Donahue; Christopher M O'Connor
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Circulation. Heart failure 2012;5(1):72-8.
2011: Christopher M O'Connor; Linda K Shaw; Li-Joy Wang; Clyde Yancy; Peter Carson; Patricia Connolly; Mona Fiuzat; Joann Lindenfeld; Carlo Lombardi; Alan Miller; Roger Mills; Kenneth Mahaffey
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes.
The American journal of cardiology 2011;108(10):1449-57.
2011: W Schuyler Jones; Christopher M O'Connor; Manesh R Patel; J Kevin Harrison; Sara A Holleran; Harry R Phillips
Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
American heart journal 2011;162(5):932-7.
2011: Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Daniel Bloomfield; John Cleland; Gad Cotter; Beth A Davison; Paul Delucca; Howard C Dittrich; Mona Fiuzat; Kenji Fujita; Michael M Givertz; Gang Jia; Carlo Lombardi; George Mansoor; Barry M Massie; Marco Metra
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
Circulation. Heart failure 2011;4(6):724-32.
2011: Thomas J Povsic; Rhonda Roberts; Richard Schatz; Richard Spencer; Andrew Taussig; John H Alexander; Missy Banks; F David Fortuin; Timothy Henry; Diane Joseph; Dean J Kereiakes; Alan Niederman; Christopher M O'Connor; Douglas Owens; Warren Sherman
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.
American heart journal 2011;162(4):654-662.e1.
2011: Robert J Mentz; Christopher M O'Connor
Cardiorenal syndrome clinical trial end points.
Heart failure clinics 2011;7(4):519-28.
2011: Christopher M O'Connor; Robert J Mentz; David J Whellan
Covariate adjustment in heart failure randomized controlled clinical trials: a case analysis of the HF-ACTION trial.
Heart failure clinics 2011;7(4):497-500.
2011: Christopher M O'Connor; Mona Fiuzat
Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.
Heart failure clinics 2011;7(4):451-6.
2011: Christopher M O'Connor; Mona Fiuzat
Clinical trials in acute decompensated heart failure--over 50 years of research.
Heart failure clinics 2011;7(4):xv-xvii.
2011: Robb D Kociol; Christopher M O'Connor; Eric M Reyes; Linda K Shaw; G Michael Felker; Gregg C Fonarow; John R Horton; Adrian F Hernandez
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
Circulation. Heart failure 2011;4(5):628-36.
2011: Ryenn West; Gregg C Fonarow; Robb Kociol; Li Liang; Roger M Mills; Christopher M O'Connor; Adrian F Hernandez
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry.
European journal of heart failure 2011;13(9):945-52.
2011: Christopher M O'Connor; Karl Swedberg; Michael Caron; Peter E Carson; Gordon W Davis; Mona Fiuzat; Wendy Gattis-Stough; Bruce Koch; Michael R Bristow
Influence of global region on outcomes in heart failure β-blocker trials.
Journal of the American College of Cardiology 2011;58(9):915-22.
2011: Allen E Atchley; Ami E Iskandrian; Daniel R Bensimhon; Stephen J Ellis; Dalane W Kitzman; Linda K Shaw; Robert A Pagnanelli; David Whellan; Julius M Gardin; Andrew Kao; Khaled Abdul-Nour; Greg Ewald; Mary Norine Walsh; William E Kraus; Christopher M O'Connor; Salvador Borges-Neto
Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial.
American heart journal 2011;161(6):1038-45.
2011: Eric J Velazquez; Kerry L Lee; Marek A Deja; Anil Jain; George Sopko; Andrey Marchenko; Imtiaz S Ali; Gerald Pohost; Sinisa Gradinac; William T Abraham; Michael Yii; Dorairaj Prabhakaran; Hanna Szwed; Paolo Ferrazzi; Mark C Petrie; Christopher M O'Connor; Pradit Panchavinnin; Lilin She; Robert O Bonow; Gena Roush Rankin; Robert H Jones; Jean-Lucien Rouleau
Coronary-artery bypass surgery in patients with left ventricular dysfunction.
The New England journal of medicine 2011;364(17):1607-16.
2011: Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; J Thomas Heywood; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy
Associations between outpatient heart failure process-of-care measures and mortality.
Circulation 2011;123(15):1601-10.
2011: Andrew Sherwood; Christopher M O'Connor; Faye S Routledge; Alan L Hinderliter; Lana L Watkins; Michael A Babyak; Gary G Koch; Kirkwood F Adams; Carla Sueta Dupree; Patricia P Chang; Benson M Hoffman; Julie Johnson; Margaret Bowers; Kristy S Johnson; James A Blumenthal
Coping effectively with heart failure (COPE-HF): design and rationale of a telephone-based coping skills intervention.
Journal of cardiac failure 2011;17(3):201-7.
2011: Kenneth W Mahaffey; June L Wampole; Amanda Stebbins; Lisa G Berdan; Donna McAfee; Tyrus L Rorick; John K French; Neal S Kleiman; Christopher M O'Connor; Eric A Cohen; Christopher B Granger; Paul W Armstrong
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Contemporary clinical trials 2011;32(2):178-87.
2011: Wei Jiang; Ranga Krishnan; Maragatha Kuchibhatla; Michael S Cuffe; Carolyn Martsberger; RM Arias; Christopher M O'Connor
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
The American journal of cardiology 2011;107(4):545-51.
2011: Mihai Gheorghiade; Peter S Pang; Christopher M O'Connor; Krishna Prasad; John McMurray; John R Teerlink; Mona Fiuzat; Hani N Sabbah; Michel Komajda
Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase.
American heart journal 2011;161(2):224-32.
2011: Christopher M O'Connor; Walter J Koch; Douglas L Mann
Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010.
Journal of cardiac failure 2011;17(2):92-9.
2011: Andrew Sherwood; James A Blumenthal; Alan L Hinderliter; Gary G Koch; Kirkwood F Adams; Carla Sueta Dupree; Daniel R Bensimhon; Kristy S Johnson; Ranak Trivedi; Margaret Bowers; Robert H Christenson; Christopher M O'Connor
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure.
Journal of the American College of Cardiology 2011;57(4):418-23.
2011: Christopher M O'Connor; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Patches Johnson Inge; Mandeep R Mehra; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy; Gregg C Fonarow
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial).
The American journal of cardiology 2011;107(2):250-8.
2010: Kirkwood F Adams; Mandeep R Mehra; Ron M Oren; Christopher M O'Connor; Jun R Chiong; Jalal K Ghali; Daniel J Lenihan; Stephanie H Dunlap; J Herbert Patterson; Todd A Schwartz; G Michael Felker
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.
American heart journal 2010;160(6):1142-8.
2010: Mona Fiuzat; Linda K Shaw; Laine Thomas; G Michael Felker; Christopher M O'Connor
United States stock market performance and acute myocardial infarction rates in 2008-2009 (from the Duke Databank for Cardiovascular Disease).
The American journal of cardiology 2010;106(11):1545-9.
2010: Jean L Rouleau; Robert Michler; Eric J Velazquez; Jae K Oh; Christopher M O'Connor; Patrice Desvigne Nickens; George Sopko; Kerry L Lee; Robert H Jones
The STICH trial: evidence-based conclusions.
European journal of heart failure 2010;12(10):1028-30.
2010: Robb D Kociol; Peter S Pang; Mihai Gheorghiade; Gregg C Fonarow; Christopher M O'Connor; G Michael Felker
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.
Journal of the American College of Cardiology 2010;56(14):1071-8.
2010: Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; RM Arias; Sarah K Rivelli; Ranga Krishnan
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
Journal of the American College of Cardiology 2010;56(9):692-9.
2010: Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Patches Johnson Inge; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Circulation 2010;122(6):585-96.
2010: Robert H Jones; Harvey White; Eric J Velazquez; Linda K Shaw; Ricardo Pietrobon; Julio A Panza; Robert O Bonow; George Sopko; Christopher M O'Connor; Jean-Lucien Rouleau
STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment.
Journal of the American College of Cardiology 2010;56(6):490-8.
2010: Ryenn L West; Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Robert M Califf
A review of dyspnea in acute heart failure syndromes.
American heart journal 2010;160(2):209-14.
2010: Thomas J Povsic; Christopher M O'Connor
Cell therapy for heart failure: the need for a new therapeutic strategy.
Expert review of cardiovascular therapy 2010;8(8):1107-26.
2010: Christopher M O'Connor; Mona Fiuzat
Is rehospitalization after heart failure admission a marker of poor quality? Time for re-evaluation.
Journal of the American College of Cardiology 2010;56(5):369-71.
2010: Jonathan P Piccini; Aijing Z Starr; John R Horton; Linda K Shaw; Kerry L Lee; Sana M Al-Khatib; Ami E Iskandrian; Christopher M O'Connor; Salvador Borges-Neto
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%.
Journal of the American College of Cardiology 2010;56(3):206-14.
2010: Shelby D Reed; David Whellan; Yanhong Li; Joëlle Y Friedman; Stephen J Ellis; Ileana L Piña; Sharon J Settles; Linda Davidson-Ray; Johanna L Johnson; Lawton S Cooper; Christopher M O'Connor; Kevin A Schulman
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.
Circulation. Cardiovascular quality and outcomes 2010;3(4):374-81.
2010: Kirkwood F Adams; G Michael Felker; Ghassan Fraij; J Herbert Patterson; Christopher M O'Connor
Biomarker guided therapy for heart failure: focus on natriuretic peptides.
Heart failure reviews 2010;15(4):351-70.
2010: Larry A Allen; Aslan T Turer; Tracy Dewald; Wendy Gattis Stough; Gadi Cotter; Christopher M O'Connor
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
The American journal of cardiology 2010;105(12):1794-7.
2010: Nancy M Albert; Gregg C Fonarow; Clyde W Yancy; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark McBride; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
The American journal of cardiology 2010;105(12):1773-9.
2010: Glen L Xiong; Wei Jiang; Robert M Clare; Linda K Shaw; Peter K Smith; Christopher M O'Connor; K Ranga; Ranga Krishnan; L Kristin Newby
Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.
Clinical cardiology 2010;33(6):E94-8.
2010: David C Steffens; K Ranga R Krishnan; Edward D Karoly; Matthew W Mitchell; Christopher M O'Connor; Rima Kaddurah-Daouk
Metabolomic differences in heart failure patients with and without major depression.
Journal of geriatric psychiatry and neurology 2010;23(2):138-46.
2010: Christopher M O'Connor; Alan B Miller; John E A Blair; Marvin A Konstam; Patricia Wedge; Maria Cecilia Bahit; Peter Carson; Markus Haass; Paul J Hauptman; Marco Metra; Ron M Oren; Richard Patten; Ileana L Piña; Sherryn Roth; Jonathan D Sackner-Bernstein; Brian Traver; Thomas Cook; Mihai Gheorghiade
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
American heart journal 2010;159(5):841-849.e1.
2010: Christopher M O'Connor; Vic Hasselblad; Rajendra H Mehta; Gudaye Tasissa; Robert M Califf; Mona Fiuzat; Joseph G Rogers; Carl V Leier; Lynne W Stevenson
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.
Journal of the American College of Cardiology 2010;55(9):872-8.
2010: G Michael Felker; Peter S Pang; Kirkwood F Adams; John G F Cleland; Gad Cotter; Kenneth Dickstein; Gerasimos S Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep R Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Ileana L Pina; Piotr Ponikowski; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Mihai Gheorghiade
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
Circulation. Heart failure 2010;3(2):314-25.
2010: Nancy M Albert; Gregg C Fonarow; Clyde W Yancy; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark McBride; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
American heart journal 2010;159(2):238-44.
2010: Clyde W Yancy; Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).
The American journal of cardiology 2010;105(2):255-60.
2010: Adrian F Hernandez; Gregg C Fonarow; Bradley G Hammill; Sana M Al-Khatib; Clyde W Yancy; Christopher M O'Connor; Kevin Schulman; Eric D Peterson; Lesley H Curtis
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
Circulation. Heart failure 2010;3(1):7-13.
2009: Allen E Atchley; Dalane W Kitzman; David Whellan; Ami E Iskandrian; Stephen J Ellis; Robert A Pagnanelli; Andrew Kao; Khaled Abdul-Nour; Christopher M O'Connor; Greg Ewald; William E Kraus; Salvador Borges-Neto
Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.
American heart journal 2009;158(4 Suppl):S53-63.
2009: G Michael Felker; David Whellan; William E Kraus; Robert Clare; Faiez Zannad; Mark P Donahue; Kirkwood F Adams; Robert McKelvie; Ileana L Piña; Christopher M O'Connor
N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
American heart journal 2009;158(4 Suppl):S37-44.
2009: Christopher M O'Connor; David Whellan
Understanding heart failure through the HF-ACTION baseline characteristics.
American heart journal 2009;158(4 Suppl):S1-5.
2009: David Whellan; Stephen J Ellis; William E Kraus; Katie Hawthorne; Ileana L Piña; Steven J Keteyian; Dalane W Kitzman; Lawton Cooper; Kerry Lee; Christopher M O'Connor
Method for establishing authorship in a multicenter clinical trial.
Annals of internal medicine 2009;151(6):414-20.
2009: G Michael Felker; Vic Hasselblad; Adrian F Hernandez; Christopher M O'Connor
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
American heart journal 2009;158(3):422-30.
2009: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF).
The American journal of cardiology 2009;104(1):107-15.
2009: Larry A Allen; Adrian F Hernandez; Christopher M O'Connor; G Michael Felker
End points for clinical trials in acute heart failure syndromes.
Journal of the American College of Cardiology 2009;53(24):2248-58.
2009: James D Flaherty; Joseph Rossi; Gregg C Fonarow; Eduardo Nunez; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Clyde W Yancy; James B Young; Charles J Davidson; Mihai Gheorghiade
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2009;157(6):1018-25.
2009: Mihai Gheorghiade; Kirkwood F Adams; John G F Cleland; Gad Cotter; G Michael Felker; Gerasimos Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Peter S Pang; Ileana L Piña; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Norman Stockbridge
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
American heart journal 2009;157(6):957-70.
2009: Kirkwood F Adams; J Herbert Patterson; John H Patterson; Ron M Oren; Mandeep Mehra; Christopher M O'Connor; Ileana L Piña; Alan B Miller; Jun R Chiong; Stephanie H Dunlap; William G Cotts; Gary M Felker; Douglas D Schocken; Todd A Schwartz; Jalal K Ghali
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.
American heart journal 2009;157(5):926-32.
2009: Jonathan P Piccini; Jeffrey S Berger; Christopher M O'Connor
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.
European heart journal 2009;30(10):1245-53.
2009: Robert H Jones; Eric J Velazquez; Robert Michler; George Sopko; Jae K Oh; Christopher M O'Connor; James A Hill; Lorenzo Menicanti; Zygmunt Sadowski; Patrice Desvigne Nickens; Jean-Lucien Rouleau; Kerry L Lee
Coronary bypass surgery with or without surgical ventricular reconstruction.
The New England journal of medicine 2009;360(17):1705-17.
2009: Christopher M O'Connor; David Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
JAMA : the journal of the American Medical Association 2009;301(14):1439-50.
2009: Clyde W Yancy; Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
American heart journal 2009;157(4):754-62.e2.
2009: Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barrie Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
American heart journal 2009;157(2):271-7.
2009: Adrian F Hernandez; Bradley G Hammill; Christopher M O'Connor; Kevin Schulman; Lesley H Curtis; Gregg C Fonarow
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.
Journal of the American College of Cardiology 2009;53(2):184-92.
2009: G Michael Felker; Christopher M O'Connor; Eugene Braunwald
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?
Circulation. Heart failure 2009;2(1):56-62.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
The American journal of cardiology 2008;102(11):1524-9.
2008: Joseph Rossi; James D Flaherty; Gregg C Fonarow; Eduardo Nunez; Wendy Gattis-Stough; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Clyde W Yancy; James B Young; Charles J Davidson; Mihai Gheorghiade
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
European journal of heart failure 2008;10(12):1215-23.
2008: Adrian F Hernandez; Alisa M Shea; Carmelo A Milano; Joseph G Rogers; Bradley G Hammill; Christopher M O'Connor; Kevin Schulman; eric peterson; Lesley H Curtis
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.
JAMA : the journal of the American Medical Association 2008;300(20):2398-406.
2008: Lynne Warner Stevenson; Anne S Hellkamp; Carl V Leier; George Sopko; Todd M Koelling; J Wayne Warnica; William T Abraham; Edward K Kasper; Joseph G Rogers; Robert M Califf; Elizabeth E Schramm; Christopher M O'Connor
Changing preferences for survival after hospitalization with advanced heart failure.
Journal of the American College of Cardiology 2008;52(21):1702-8.
2008: Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Rajendra H Mehta; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan
Antidepressant use, depression, and survival in patients with heart failure.
Archives of internal medicine 2008;168(20):2232-7.
2008: David Whellan; Christopher M O'Connor; Kevin T Ousdigian; Te-Hsin Lung
Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
American heart journal 2008;156(5):833-9, 839.e2.
2008: Larry A Allen; Marco Metra; Olga Milo-Cotter; Gerasimos Filippatos; Leonardo H Reisin; Daniel R Bensimhon; Edoardo G Gronda; Paolo Colombo; G Michael Felker; Livio Dei Cas; Dimitrios T Kremastinos; Christopher M O'Connor; Gadi Cotter; Beth A Davison; Howard C Dittrich; Eric J Velazquez
Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF).
Journal of cardiac failure 2008;14(9):777-84.
2008: Larry A Allen; Joseph G Rogers; J Wayne Warnica; Thomas G Disalvo; Gudaye Tasissa; Cynthia Binanay; Christopher M O'Connor; Robert M Califf; Carl V Leier; Monica R Shah; Lynne Warner Stevenson
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization.
Journal of cardiac failure 2008;14(8):661-9.
2008: Christopher M O'Connor; William T Abraham; Nancy M Albert; Robert Clare; Wendy Gattis-Stough; Mihai Gheorghiade; Barry H Greenberg; Clyde W Yancy; James B Young; Gregg C Fonarow
Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2008;156(4):662-73.
2008: Daniel R Bensimhon; Eric S Leifer; Stephen J Ellis; Jerome L Fleg; Steven J Keteyian; Ileana L Piña; Dalane W Kitzman; Robert S McKelvie; William E Kraus; Daniel E Forman; Andrew J Kao; David Whellan; Christopher M O'Connor; Stuart D Russell
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).
The American journal of cardiology 2008;102(6):712-7.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Eduardo Nunez; Clyde W Yancy; James B Young
A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF.
European heart journal 2008;29(16):1983-91.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
Journal of the American College of Cardiology 2008;52(3):190-9.
2008: Gregg C Fonarow; Clyde W Yancy; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Circulation. Heart failure 2008;1(2):98-106.
2008: Richard C Becker; Thomas W Meade; Peter B Berger; Michael Ezekowitz; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt; Daniel B Mark; Robert A Harrington
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):776S-814S.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Eduardo Nunez; Clyde W Yancy; James B Young
Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Circulation. Heart failure 2008;1(1):50-7.
2008: Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Circulation. Heart failure 2008;1(1):25-33.
2008: Clyde W Yancy; William T Abraham; Nancy M Albert; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; James B Young; Gregg C Fonarow
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry.
Journal of the American College of Cardiology 2008;51(17):1675-84.
2008: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.
Archives of internal medicine 2008;168(8):847-54.
2008: Monica R Shah; David Whellan; Eric D Peterson; Anju Nohria; Vic Hasselblad; Zhenyi Xue; Margaret T Bowers; Christopher M O'Connor; Robert M Califf; Lynne Warner Stevenson
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of care.
American heart journal 2008;155(4):764.e1-5.
2008: Olga Milo-Cotter; Gad Cotter; Beth D Weatherley; Kirkwood F Adams; Edo Kaluski; Nir Uriel; Christopher M O'Connor; G Michael Felker
Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia.
European journal of heart failure 2008;10(2):196-200.
2008: James B Young; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; Clyde W Yancy; Gregg C Fonarow
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
The American journal of cardiology 2008;101(2):223-30.
2008: Gad Cotter; G Michael Felker; Kirkwood F Adams; Olga Milo-Cotter; Christopher M O'Connor
The pathophysiology of acute heart failure--is it all about fluid accumulation?
American heart journal 2008;155(1):9-18.
2007: Eric J Velazquez; Kerry L Lee; Christopher M O'Connor; Jae K Oh; Robert O Bonow; Gerald M Pohost; Arthur M Feldman; Daniel B Mark; Julio A Panza; George Sopko; Jean-Lucien Rouleau; Robert H Jones
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
The Journal of thoracic and cardiovascular surgery 2007;134(6):1540-7.
2007: john mcmurray; John R Teerlink; Gad Cotter; Robert Bourge; John G F Cleland; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Jim Lewsey; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;298(17):2009-19.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Journal of cardiac failure 2007;13(9):722-31.
2007: Monica R Shah; Vic Hasselblad; Gudaye Tasissa; Robert H Christenson; Cynthia Binanay; Christopher M O'Connor; Erik Ohman; Lynne Warner Stevenson; Robert M Califf
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
The American journal of cardiology 2007;100(9):1427-33.
2007: Mihai Gheorghiade; Joseph Rossi; William G Cotts; David D Shin; Anne S Hellkamp; Ileana L Piña; Gregg C Fonarow; Teresa DeMarco; Daniel F Pauly; Joseph Rogers; Thomas G DiSalvo; Javed Butler; Joshua M Hare; Gary S Francis; Wendy Gattis Stough; Christopher M O'Connor
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
Archives of internal medicine 2007;167(18):1998-2005.
2007: Christopher M O'Connor; Pradeep Arumugham
Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
Heart failure clinics 2007;3(4):477-84.
2007: Vic Hasselblad; Wendy Gattis-Stough; Monica R Shah; Yuliya Lokhnygina; Christopher M O'Connor; Robert M Califf; Kirkwood F Adams
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
European journal of heart failure 2007;9(10):1064-9.
2007: Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Journal of the American College of Cardiology 2007;50(8):768-77.
2007: Barry H Greenberg; William T Abraham; Nancy M Albert; Karen Chiswell; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young; Gregg C Fonarow
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2007;154(2):277.e1-8.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Archives of internal medicine 2007;167(14):1493-502.
2007: Wei Jiang; Maragatha Kuchibhatla; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Relationship between depressive symptoms and long-term mortality in patients with heart failure.
American heart journal 2007;154(1):102-8.
2007: Daniel R Bensimhon; George L Adams; David Whellan; Robert A Pagnanelli; Mark Trimble; Benjamin A Lee; Kerry L Lee; Stephen J Ellis; William E Kraus; David S Rendall; Ami E Iskandrian; Christopher M O'Connor; Salvador Borges-Neto
Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: a nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION); design and rationale.
American heart journal 2007;154(1):46-53.
2007: Gregg C Fonarow; Clyde W Yancy; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mandeep Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
American heart journal 2007;154(1):12-38.
2007: Nancy M Albert; Gregg C Fonarow; William T Abraham; Karen Chiswell; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF.
Journal of cardiac failure 2007;13(3):189-98.
2007: Harry R Phillips; Christopher M O'Connor; Joseph Rogers
Revascularization for heart failure.
American heart journal 2007;153(4 Suppl):65-73.
2007: Christopher M O'Connor
The new heart failure guidelines: strategies for implementation.
American heart journal 2007;153(4 Suppl):2-5.
2007: Jamieson M Bourque; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; Salvador Borges-Neto
Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2007;14(2):165-73.
2007: Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis-Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
European heart journal 2007;28(8):980-8.
2007: Larry A Allen; Christopher M O'Connor
Management of acute decompensated heart failure.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;176(6):797-805.
2007: Pradeep S Arumugham; Christopher M O'Connor
Nonpharmacologic therapy in heart failure: an overview.
Current heart failure reports 2007;4(1):33-8.
2007: Alex I Malinin; Benjamin R Oshrine; David C Sane; Christopher M O'Connor; Victor L Serebruany
Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(2):91-6.
2007: Andrew Sherwood; James A Blumenthal; Ranak Trivedi; Kristy S Johnson; Christopher M O'Connor; Kirkwood F Adams; Carla Dupree; Robert A Waugh; Daniel R Bensimhon; Laura H Gaulden; Robert H Christenson; Gary G Koch; Alan L Hinderliter
Relationship of depression to death or hospitalization in patients with heart failure.
Archives of internal medicine 2007;167(4):367-73.
2007: David Whellan; Christopher M O'Connor; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin Schulman; Ileana L Piña
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.
American heart journal 2007;153(2):201-11.
2007: Christopher M O'Connor; Pradeep Arumugham
Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
Clinics in geriatric medicine 2007;23(1):141-53.
2007: Olga Milo-Cotter; Kirkwood F Adams; Christopher M O'Connor; Nir Uriel; Edo Kaluski; G Michael Felker; Beth Weatherley; Zvi Vered; Gad Cotter
Acute heart failure associated with high admission blood pressure--a distinct vascular disorder?
European journal of heart failure 2007;9(2):178-83.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Association between performance measures and clinical outcomes for patients hospitalized with heart failure.
JAMA : the journal of the American Medical Association 2007;297(1):61-70.
2007: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2007;153(1):82.e1-11.
2006: Melvin R Echols; G Michael Felker; Kevin L Thomas; Karen S Pieper; Jyotsna Garg; Michael S Cuffe; Mihai Gheorghiade; Robert M Califf; Christopher M O'Connor
Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
Journal of cardiac failure 2006;12(9):684-8.
2006: Mihai Gheorghiade; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Lilin She; Wendy Gattis Stough; Clyde W Yancy; James B Young; Gregg C Fonarow
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
JAMA : the journal of the American Medical Association 2006;296(18):2217-26.
2006: Jamieson M Bourque; Christopher M O'Connor; Eric J Velazquez
Letter by Bourque et al regarding article, "Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994".
Circulation 2006;114(7):e255.
2006: David Whellan; Robert H Tuttle; Eric J Velazquez; Linda K Shaw; James G Jollis; Wendell Ellis; Christopher M O'Connor; Robert M Califf; Salvador Borges-Neto
Predicting significant coronary artery disease in patients with left ventricular dysfunction.
American heart journal 2006;152(2):340-7.
2006: David Aguilar; Marian R Fisher; Christopher M O'Connor; Michael W Dunne; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Thomas D Cook; Dearborn Edwards; Marc A Pfeffer
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.
American heart journal 2006;152(2):298-304.
2006: Glen L Xiong; Wei Jiang; Robert Clare; Linda K Shaw; Peter K Smith; Kenneth W Mahaffey; Christopher M O'Connor; K Ranga Rama Krishnan; L Kristin Newby
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.
The American journal of cardiology 2006;98(1):42-7.
2006: Milton Packer; William T Abraham; Mandeep Mehra; Clyde W Yancy; Christine E Lawless; Judith E Mitchell; Frank W Smart; Rachel Bijou; Christopher M O'Connor; Barrie Massie; Ileana Pina; Barry H Greenberg; James B Young; Daniel P Fishbein; Paul J Hauptman; Robert Bourge; John E Strobeck; Srinvivas Murali; Douglas Schocken; John R Teerlink; Wayne C Levy; Robin J Trupp; Marc A Silver
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
Journal of the American College of Cardiology 2006;47(11):2245-52.
2006: G Michael Felker; Linda K Shaw; Wendy Gattis Stough; Christopher M O'Connor
Anemia in patients with heart failure and preserved systolic function.
American heart journal 2006;151(2):457-62.
2006: G Michael Felker; Wendy Gattis Stough; Linda K Shaw; Christopher M O'Connor
Anaemia and coronary artery disease severity in patients with heart failure.
European journal of heart failure 2006;8(1):54-7.
2005: Monica R Shah; Karen A Claise; Margaret T Bowers; Manjushri Bhapkar; Julie Little; Anju Nohria; Laura H Gaulden; Vickie K McKee; Kara L Cozart; Karen L Mancinelli; Helen Daniels; Tesca Kinard; Lynne Warner Stevenson; Donna M Mancini; Christopher M O'Connor; Robert M Califf
Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.
American heart journal 2005;150(5):893-8.
2005: Adrian F Hernandez; Eric J Velazquez; Scott D Solomon; Rakhi Kilaru; Rafael Diaz; Christopher M O'Connor; George Ertl; Aldo P Maggioni; Jean-Lucien Rouleau; Wiek H van Gilst; Marc A Pfeffer; Robert M Califf
Left ventricular assessment in myocardial infarction: the VALIANT registry.
Archives of internal medicine 2005;165(18):2162-9.
2005: Monica R Shah; Vic Hasselblad; Lynne Warner Stevenson; Cynthia Binanay; Christopher M O'Connor; George Sopko; Robert M Califf
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials.
JAMA : the journal of the American Medical Association 2005;294(13):1664-70.
2005: Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne Warner Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
JAMA : the journal of the American Medical Association 2005;294(13):1625-33.
2005: Kevin L Thomas; Mark A East; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; eric peterson
Outcomes by race and etiology of patients with left ventricular systolic dysfunction.
The American journal of cardiology 2005;96(7):956-63.
2005: Wendy Gattis Stough; Christopher M O'Connor; Mihai Gheorghiade
Overview of current noninodilator therapies for acute heart failure syndromes.
The American journal of cardiology 2005;96(6A):41G-6G.
2005: Mihai Gheorghiade; Wendy Gattis-Stough; Kirkwood F Adams; Allan S Jaffe; Vic Hasselblad; Christopher M O'Connor
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
The American journal of cardiology 2005;96(6A):18G-25G.
2005: Victor L Serebruany; Christopher M O'Connor; Ranga R Krishnan; Charles H Hennekens
Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.
Journal of cardiovascular pharmacology and therapeutics 2005;10(3):163-4.
2005: Jacob N Schroder; Matthew L Williams; Jonathan A Hata; Lawrence H Muhlbaier; Madhav Swaminathan; Joseph P Mathew; Donald D Glower; Christopher M O'Connor; Peter K Smith; Carmelo A Milano
Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting.
Circulation 2005;112(9 Suppl):I293-8.
2005: Wei Jiang; Alexander Glassman; Ranga Krishnan; Christopher M O'Connor; Robert M Califf
Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
American heart journal 2005;150(1):54-78.
2005: John R Teerlink; john mcmurray; Robert Bourge; John G F Cleland; Gad Cotter; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
American heart journal 2005;150(1):46-53.
2005: Victor L Serebruany; Raymond F Suckow; Thomas B Cooper; Christopher M O'Connor; Alex I Malinin; K Ranga Rama Krishnan; Louis T van Zyl; Vladimir Lekht; Alexander H Glassman
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
The American journal of psychiatry 2005;162(6):1165-70.
2005: Liviu Klein; Christopher M O'Connor; Jeffrey D Leimberger; Wendy Gattis-Stough; Ileana L Piña; G Michael Felker; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Circulation 2005;111(19):2454-60.
2005: Karen E Joynt; Christopher M O'Connor
Lessons from SADHART, ENRICHD, and other trials.
Psychosomatic medicine 2005;67 Suppl 1():S63-6.
2005: Sana M Al-Khatib; Kevin J Anstrom; Eric L Eisenstein; eric peterson; James G Jollis; Daniel B Mark; Yun Li; Christopher M O'Connor; Linda K Shaw; Robert M Califf
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
Annals of internal medicine 2005;142(8):593-600.
2005: David Whellan; Vic Hasselblad; Eric Peterson; Christopher M O'Connor; Kevin Schulman
Metaanalysis and review of heart failure disease management randomized controlled clinical trials.
American heart journal 2005;149(4):722-9.
2005: Christopher M O'Connor; Wendy Gattis Stough; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.
Journal of cardiac failure 2005;11(3):200-5.
2005: Christopher M O'Connor; Alexander H Glassman; David J Harrison
Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
The Journal of clinical psychiatry 2005;66(3):346-52.
2005: Christopher M O'Connor; Steven Gottlieb; Jamieson M Bourque; Heidi Krause-Steinrauf; Inder S Anand; Jeffrey L Anderson; Jonathan F Plehn; Marc A Silver; Michel White; Peter Carson
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
The American journal of cardiology 2005;95(5):558-64.
2004: G Michael Felker; Jeffrey D Leimberger; Robert M Califf; Michael S Cuffe; Barrie Massie; Kirkwood F Adams; Mihai Gheorghiade; Christopher M O'Connor
Risk stratification after hospitalization for decompensated heart failure.
Journal of cardiac failure 2004;10(6):460-6.
2004: Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Prognostic value of anxiety and depression in patients with chronic heart failure.
Circulation 2004;110(22):3452-6.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Victor L Serebruany; Mark G Midei; Alex I Malinin; Benjamin R Oshrine; David R Lowry; David C Sane; Jean-François Tanguay; Steven R Steinhubl; Peter B Berger; Christopher M O'Connor; Charles H Hennekens
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Archives of internal medicine 2004;164(18):2051-7.
2004: Adrian F Hernandez; David Whellan; Sharon Stroud; Jie Lena Sun; Christopher M O'Connor; James G Jollis
Outcomes in heart failure patients after major noncardiac surgery.
Journal of the American College of Cardiology 2004;44(7):1446-53.
2004: David Aguilar; Scott D Solomon; Lars Køber; Jean-Lucien Rouleau; Hicham Skali; john mcmurray; Gary S Francis; Marc Henis; Christopher M O'Connor; Rafael Diaz; Yuri N Belenkov; Sergei Varshavsky; Jeffrey D Leimberger; Eric J Velazquez; Robert M Califf; Marc A Pfeffer
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Circulation 2004;110(12):1572-8.
2004: Adrian F Hernandez; L Kristin Newby; Christopher M O'Connor
Preoperative evaluation for major noncardiac surgery: focusing on heart failure.
Archives of internal medicine 2004;164(16):1729-36.
2004: Robert A Harrington; Richard C Becker; Michael D Ezekowitz; Thomas W Meade; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):513S-548S.
2004: G Michael Felker; Kirkwood F Adams; Wendy A Gattis; Christopher M O'Connor
Anemia as a risk factor and therapeutic target in heart failure.
Journal of the American College of Cardiology 2004;44(5):959-66.
2004: Raymond L Benza; Jose A Tallaj; G Michael Felker; K Michael Zabel; Walter Kao; Robert Bourge; Douglas Pearce; Jeffrey D Leimberger; Steven Borzak; Christopher M O'Connor; Mihai Gheorghiade
The impact of arrhythmias in acute heart failure.
Journal of cardiac failure 2004;10(4):279-84.
2004: S Susan Hedayati; Wei Jiang; Christopher M O'Connor; Maragatha Kuchibhatla; K Ranga Rama Krishnan; Michael S Cuffe; Michael A Blazing; Lynda A Szczech
The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):207-15.
2004: Mark A East; eric peterson; Linda K Shaw; Wendy A Gattis; Christopher M O'Connor
Racial differences in the outcomes of patients with diastolic heart failure.
American heart journal 2004;148(1):151-6.
2004: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy A Gattis; Mihai Gheorghiade; Barry Greenberg; Christopher M O'Connor; Clyde W Yancy; James Young
Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
American heart journal 2004;148(1):43-51.
2004: Karen E Joynt; David Whellan; Christopher M O'Connor
Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.
Journal of cardiac failure 2004;10(3):258-71.
2004: Wendy A Gattis; Christopher M O'Connor; Vic Hasselblad; Kirkwood F Adams; Isaac Kobrin; Mihai Gheorghiade
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).
The American journal of cardiology 2004;93(11):1436-7, A10.
2004: Wendy A Gattis; Christopher M O'Connor
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure.
The American journal of cardiology 2004;93(9A):74B-6B.
2004: Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Journal of the American College of Cardiology 2004;43(9):1534-41.
2004: Victor L Serebruany; Alex I Malinin; David R Lowry; David C Sane; Randy L Webb; Sidney O Gottlieb; Christopher M O'Connor; Charles H Hennekens
Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits.
Journal of cardiovascular pharmacology 2004;43(5):677-84.
2004: Mihai Gheorghiade; Wendy A Gattis; Christopher M O'Connor; Kirkwood F Adams; Uri Elkayam; Alejandro Barbagelata; Jalal K Ghali; Raymond L Benza; Frank A McGrew; Marc Klapholz; John Ouyang; Cesare Orlandi
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;291(16):1963-71.
2004: Liviu Klein; Wendy A Gattis; Francesco Borrello; Edwin Wu; Christopher M O'Connor; Mihai Gheorghiade
Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging study.
The American journal of cardiology 2004;93(8A):44A-46A.
2004: Karen E Joynt; Wendy A Gattis; Vic Hasselblad; Sergey Y Fuzaylov; Victor L Serebruany; Paul A Gurbel; Laura H Gaulden; G Michael Felker; David Whellan; Christopher M O'Connor
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
The American journal of cardiology 2004;93(6):783-5.
2004: Jamieson M Bourque; Eric J Velazquez; Salvador Borges-Neto; Linda K Shaw; David Whellan; Christopher M O'Connor
Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2004;11(2):118-25.
2004: Michael P Hudson; Christopher M O'Connor; Wendy A Gattis; Gudaye Tasissa; Vic Hasselblad; Cathy M Holleman; Laura H Gaulden; Frank A Sedor; Erik Ohman
Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
American heart journal 2004;147(3):546-52.
2004: Christopher H Cabell; Benjamin H Trichon; Eric J Velazquez; Jean Dumesnil; Kevin J Anstrom; Thomas Ryan; Alan B Miller; Robert N Belkin; Anne B Cropp; Christopher M O'Connor; James G Jollis
Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study.
American heart journal 2004;147(1):151-7.
2003: J Robert Swenson; Christopher M O'Connor; David Barton; Louis T van Zyl; Karl Swedberg; Leslie M Forman; Michael Gaffney; Alexander H Glassman
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.
The American journal of cardiology 2003;92(11):1271-6.
2003: Victor L Serebruany; Alex I Malinin; Scott D Jerome; David R Lowry; Athol Morgan; David C Sane; Jean-François Tanguay; Steven R Steinhubl; Christopher M O'Connor
Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
American heart journal 2003;146(4):713-20.
2003: Jamieson M Bourque; Vic Hasselblad; Eric J Velazquez; Salvador Borges-Neto; Christopher M O'Connor
Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis.
American heart journal 2003;146(4):621-7.
2003: Christopher M O'Connor; Michael W Dunne; Marc A Pfeffer; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Marian R Fisher; Thomas D Cook
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(11):1459-66.
2003: Benjamin H Trichon; Donald D Glower; Linda K Shaw; Christopher H Cabell; Kevin J Anstrom; G Michael Felker; Christopher M O'Connor
Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation.
Circulation 2003;108 Suppl 1():II103-10.
2003: Victor L Serebruany; Alexander H Glassman; Alex I Malinin; David C Sane; Mitchell S Finkel; Ranga R Krishnan; Dan Atar; Vladimir Lekht; Christopher M O'Connor
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):563-7.
2003: G Michael Felker; Wendy A Gattis; Jeffrey D Leimberger; Kirkwood F Adams; Michael S Cuffe; Mihai Gheorghiade; Christopher M O'Connor
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.
The American journal of cardiology 2003;92(5):625-8.
2003: Victor L Serebruany; Alexander H Glassman; Alex I Malinin; Charles Nemeroff; Dominique L Musselman; Louis T van Zyl; Mitchell S Finkel; K Ranga Rama Krishnan; Michael Gaffney; Wilma Harrison; Robert M Califf; Christopher M O'Connor
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Circulation 2003;108(8):939-44.
2003: Victor L Serebruany; Alexander H Glassman; Alex I Malinin; Dan Atar; David C Sane; Benjamin R Oshrine; J J Ferguson; Christopher M O'Connor
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin.
European journal of heart failure 2003;5(4):517-21.
2003: Karen E Joynt; David Whellan; Christopher M O'Connor
Depression and cardiovascular disease: mechanisms of interaction.
Biological psychiatry 2003;54(3):248-61.
2003: Victor L Serebruany; Alex I Malinin; Christopher M O'Connor; Paul A Gurbel
Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
American heart journal 2003;146(1):91-8.
2003: Wei Jiang; Michael A Babyak; Alan Rozanski; Andrew Sherwood; Christopher M O'Connor; Robert A Waugh; R Edward Coleman; Michael W Hanson; James J Morris; James A Blumenthal
Depression and increased myocardial ischemic activity in patients with ischemic heart disease.
American heart journal 2003;146(1):55-61.
2003: Liviu Klein; Christopher M O'Connor; Wendy A Gattis; Manuela Zampino; Leonardo de Luca; Antonio Vitarelli; Francesco Fedele; Mihai Gheorghiade
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
The American journal of cardiology 2003;91(9A):18F-40F.
2003: Christopher M O'Connor; Wendy A Gattis; Kirkwood F Adams; Vic Hasselblad; Bleakley Chandler; Aline Frey; Isaac Kobrin; Maurizio Rainisio; Monica R Shah; John R Teerlink; Mihai Gheorghiade
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).
Journal of the American College of Cardiology 2003;41(9):1452-7.
2003: Jamieson M Bourque; Eric J Velazquez; Salvador Borges-Neto; Linda K Shaw; David Whellan; Christopher M O'Connor
Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?
American heart journal 2003;145(5):758-67.
2003: G Michael Felker; Raymond L Benza; A Bleakley Chandler; Jeffrey D Leimberger; Michael S Cuffe; Robert M Califf; Mihai Gheorghiade; Christopher M O'Connor
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
Journal of the American College of Cardiology 2003;41(6):997-1003.
2003: Alex I Malinin; Christopher M O'Connor; Alec I Dzhanashvili; David C Sane; Victor L Serebruany
Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?
American heart journal 2003;145(3):397-403.
2003: Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.
The American journal of cardiology 2003;91(5):538-43.
2003: Mihai Gheorghiade; Kirkwood F Adams; Wendy A Gattis; John R Teerlink; Cesare Orlandi; Christopher M O'Connor
Surrogate end points in heart failure trials.
American heart journal 2003;145(2 Suppl):S67-70.
2003: Manuela Zampino; Christopher M O'Connor; Wendy A Gattis; Kirkwood F Adams; Mihai Gheorghiade
Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
American heart journal 2003;145(2 Suppl):S62-6.
2003: Mihai Gheorghiade; Wendy A Gattis; Mary Ann Lukas; Christopher M O'Connor
Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.
American heart journal 2003;145(2 Suppl):S60-1.
2003: Christopher M O'Connor; Wendy A Gattis; Kirkwood F Adams; Monica R Shah; Aline Frey; Mihai Gheorghiade
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).
American heart journal 2003;145(2 Suppl):S58-9.
2003: Mihai Gheorghiade; Wendy A Gattis; Kirkwood F Adams; Alan S Jaffe; Christopher M O'Connor
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
American heart journal 2003;145(2 Suppl):S55-7.
2003: Mihai Gheorghiade; Wendy A Gattis; Alejandro Barbagelata; Kirkwood F Adams; Uri Elkayam; Cesare Orlandi; Christopher M O'Connor
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.
American heart journal 2003;145(2 Suppl):S51-4.
2003: Christopher M O'Connor; Wendy A Gattis; John R Teerlink; Kirkwood F Adams; Mihai Gheorghiade
Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure.
American heart journal 2003;145(2 Suppl):S47-50.
2003: G Michael Felker; Kirkwood F Adams; Marvin A Konstam; Christopher M O'Connor; Mihai Gheorghiade
The problem of decompensated heart failure: nomenclature, classification, and risk stratification.
American heart journal 2003;145(2 Suppl):S18-25.
2003: Wendy A Gattis; Christopher M O'Connor; Jeffrey D Leimberger; G Michael Felker; Kirkwood F Adams; Mihai Gheorghiade
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.
The American journal of cardiology 2003;91(2):169-74.
2002: Christopher M O'Connor; Wendy A Gattis; Kirkwood F Adams; Monica R Shah; Isaac Kobrin; Aline Frey; Mihai Gheorghiade
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4).
American heart journal 2002;144(4):583-8.
2002: Benjamin H Trichon; Christopher M O'Connor
Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated?
American heart journal 2002;144(3):373-6.
2002: Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA : the journal of the American Medical Association 2002;288(6):701-9.
2002: Paul A Gurbel; Alex I Malinin; Kevin P Callahan; Victor L Serebruany; Christopher M O'Connor
Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation.
The American journal of cardiology 2002;90(3):312-5.
2002: Christopher M O'Connor; Eric J Velazquez; Laura H Gardner; Peter K Smith; Mark F Newman; Kevin Paul Landolfo; Kerry L Lee; Robert M Califf; Robert H Jones
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).
The American journal of cardiology 2002;90(2):101-7.
2002: Gerald W Neuberg; Alan B Miller; Christopher M O'Connor; Robert N Belkin; Peter E Carson; Anne B Cropp; David J Frid; Regina G Nye; Milton L Pressler; John H Wertheimer; Milton Packer
Diuretic resistance predicts mortality in patients with advanced heart failure.
American heart journal 2002;144(1):31-8.
2002: Paul A Gurbel; Wendy A Gattis; Sergey F Fuzaylov; Laura H Gaulden; Vic Hasselblad; Victor L Serebruany; Christopher M O'Connor
Evaluation of platelets in heart failure: is platelet activity related to etiology, functional class, or clinical outcomes?
American heart journal 2002;143(6):1068-75.
2002: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Judith M Kramer; Steven Grossman; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.
European journal of heart failure 2002;4(3):297-304.
2002: Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond L Benza; Robert Bourge; Wilson S Colucci; Barrie Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;287(12):1541-7.
2002: Wei Jiang; Vic Hasselblad; Ranga R Krishnan; Christopher M O'Connor
Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression.
Journal of the American College of Cardiology 2002;39(5):919-21.
2002: G Michael Felker; Linda K Shaw; Christopher M O'Connor
A standardized definition of ischemic cardiomyopathy for use in clinical research.
Journal of the American College of Cardiology 2002;39(2):210-8.
2002: Wendy A Gattis; Christopher M O'Connor; Mihai Gheorghiade
The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
Reviews in cardiovascular medicine 2002;3 Suppl 3():S48-54.
2002: Mihai Gheorghiade; Wendy A Gattis; Christopher M O'Connor
Treatment gaps in the pharmacologic management of heart failure.
Reviews in cardiovascular medicine 2002;3 Suppl 3():S11-9.
2002: Victor L Serebruany; Marcus E McKenzie; Andrew F Meister; Sergey Y Fuzaylov; Paul A Gurbel; Dan Atar; Wendy A Gattis; Christopher M O'Connor
Failure of platelet parameters and biomarkers to correlate platelet function to severity and etiology of heart failure in patients enrolled in the EPCOT trial. With special reference to the Hemodyne hemostatic analyzer. Whole Blood Impedance Aggregometry for the Assessment of Platelet Function in Patients with Congestive Heart Failure.
Pathophysiology of haemostasis and thrombosis 2002;32(1):8-15.
2002: Wei Jiang; Ranga R Krishnan; Christopher M O'Connor
Depression and heart disease: evidence of a link, and its therapeutic implications.
CNS drugs 2002;16(2):111-27.
2001: Monica R Shah; Vic Hasselblad; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.
The American journal of cardiology 2001;88(9):987-93.
2001: David Whellan; Laura H Gaulden; Wendy A Gattis; Bradi B Granger; Stuart D Russell; Michael A Blazing; Michael S Cuffe; Christopher M O'Connor
The benefit of implementing a heart failure disease management program.
Archives of internal medicine 2001;161(18):2223-8.
2001: G Michael Felker; Christopher M O'Connor
Inotropic therapy for heart failure: an evidence-based approach.
American heart journal 2001;142(3):393-401.
2001: Christopher M O'Connor; Wendy A Gattis; Anne S Hellkamp; Anatoly Langer; R L Larsen; Robert A Harrington; Scott Darrell Berkowitz; Patrick T O'Gara; Stephen L Kopecky; Mihai Gheorghiade; R Daly; Robert M Califf; V Fuster
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
The American journal of cardiology 2001;88(5):541-6.
2001: Wei Jiang; J Alexander; Eric J Christopher; Maragatha Kuchibhatla; Laura H Gaulden; Michael S Cuffe; Michael A Blazing; C Davenport; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.
Archives of internal medicine 2001;161(15):1849-56.
2001: David Whellan; Linda K Shaw; Bradley A Bart; William E Kraus; Robert M Califf; Christopher M O'Connor
Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction.
American heart journal 2001;142(1):160-6.
2001: Victor L Serebruany; Christopher M O'Connor; Paul A Gurbel
Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease.
The American journal of cardiology 2001;87(12):1398-400.
2001: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Mihai Gheorghiade; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes.
Journal of cardiac failure 2001;7(2):105-13.
2001: Monica R Shah; Sandra S Stinnett; S E McNulty; Mihai Gheorghiade; Faiez Zannad; B Uretsky; Kirkwood F Adams; Robert M Califf; Christopher M O'Connor
Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST.
American heart journal 2001;141(6):908-14.
2001: Victor L Serebruany; Paul A Gurbel; Christopher M O'Connor
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
Pharmacological research : the official journal of the Italian Pharmacological Society 2001;43(5):453-62.
2001: M R Shah; Christopher M O'Connor; G Sopko; Vic Hasselblad; Robert M Califf; L W Stevenson
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.
American heart journal 2001;141(4):528-35.
2001: Victor L Serebruany; A B Alford; Andrew F Meister; Sergey Y Fuzaylov; Wendy A Gattis; Paul A Gurbel; Christopher M O'Connor
Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial).
Thrombosis research 2001;101(6):427-33.
2000: Christopher M O'Connor; Wendy A Gattis; L Shaw; Michael S Cuffe; Robert M Califf
Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function.
The American journal of cardiology 2000;86(8):863-7.
2000: Christopher M O'Connor; Paul A Gurbel; Victor L Serebruany
Depression and ischemic heart disease.
American heart journal 2000;140(4 Suppl):63-9.
2000: Charles Nemeroff; Christopher M O'Connor
Introduction.
American heart journal 2000;140(4 Suppl):55-6.
2000: CJ Davis; Paul A Gurbel; Wendy A Gattis; Sergey Y Fuzaylov; GV Nair; Christopher M O'Connor; Victor L Serebruany
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge.
International journal of cardiology 2000;75(1):15-21.
2000: P A Carson; Christopher M O'Connor; Alan B Miller; S Anderson; Robert N Belkin; Gerald W Neuberg; John H Wertheimer; David J Frid; Anne B Cropp; Milton Packer
Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial.
Journal of the American College of Cardiology 2000;36(2):541-6.
2000: Christopher M O'Connor; Wendy A Gattis; T J Ryan
The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials.
American heart journal 2000;139(4):S143-54.
2000: A Shah; Galen S Wagner; Christopher B Granger; Christopher M O'Connor; Cynthia L Green; Kathleen M Trollinger; Robert M Califf; Mitchell W Krucoff
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
Journal of the American College of Cardiology 2000;35(3):666-72.
2000: Paul A Gurbel; DJ Kereiakes; MR Dalesandro; Raymond D Bahr; Christopher M O'Connor; Victor L Serebruany
Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department.
American heart journal 2000;139(2 Pt 1):320-8.
2000: Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Robert Bourge; Wilson S Colucci; B Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; M Silver; L A Robinson; Jeffrey D Leimberger; Mihai Gheorghiade
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
American heart journal 2000;139(1 Pt 1):15-22.
1999: Christopher M O'Connor; Wendy A Gattis; Mihai Gheorghiade; Christopher B Granger; J Gilbert; J M McKenney; F C Messineo; J C Burnett; S D Katz; Uri Elkayam; Edward K Kasper; Sidney Goldstein; robert cody; Barrie Massie
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
American heart journal 1999;138(6 Pt 1):1140-8.
1999: Carlos Del Carlo; Christopher M O'Connor
Cardiac troponins in congestive heart failure.
American heart journal 1999;138(4 Pt 1):646-53.
1999: Wendy A Gattis; V Hasselblad; David Whellan; Christopher M O'Connor
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.
Archives of internal medicine 1999;159(16):1939-45.
1999: Victor L Serebruany; SR Murugesan; A Pothula; Dan Atar; DR Lowry; Christopher M O'Connor; Paul A Gurbel
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy.
European journal of heart failure 1999;1(3):243-9.
1999: GV Nair; Paul A Gurbel; Christopher M O'Connor; Wendy A Gattis; S R Murugesan; Victor L Serebruany
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
The American journal of cardiology 1999;84(3):321-3, A8.
1999: Paul A Gurbel; Christopher M O'Connor; C C Cummings; Victor L Serebruany
Clopidogrel: the future choice for preventing platelet activation during coronary stenting?
Pharmacological research : the official journal of the Italian Pharmacological Society 1999;40(2):107-11.
1999: Christopher M O'Connor; P W Radensky; A N Unger; B C Martin
Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.
Clinical therapeutics 1999;21(7):1254-65.
1999: Christopher M O'Connor; Wendy A Gattis; Karl Swedberg
Current and novel pharmacologic approaches in advanced heart failure.
Heart & lung : the journal of critical care 1999;28(4):227-42.
1999: Christopher M O'Connor; Wendy A Gattis; B F Uretsky; Kirkwood F Adams; SE McNulty; S H Grossman; WJ McKenna; F Zannad; Karl Swedberg; Mihai Gheorghiade; Robert M Califf
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
American heart journal 1999;138(1 Pt 1):78-86.
1999: Peter A Shapiro; François Lespérance; Nancy Frasure-Smith; Christopher M O'Connor; B Baker; J W Jiang; Paul Dorian; W Harrison; Alexander H Glassman
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
American heart journal 1999;137(6):1100-6.
1999: Christopher M O'Connor; Paul A Gurbel; Victor L Serebruany
Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.
The American journal of cardiology 1999;83(9):1345-9.
1999: David Whellan; Wendy A Gattis; Laura H Gaulden; Bradi B Granger; Christopher M O'Connor
Disease management of congestive heart failure.
The American journal of managed care 1999;5(4):499-507; quiz 508-9.
1999: Christopher M O'Connor; Wendy A Gattis; F Zannad; SE McNulty; Mihai Gheorghiade; Kirkwood F Adams; Robert M Califf; WJ McKenna; J Soler-Soler; Karl Swedberg
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
European journal of heart failure 1999;1(1):81-8.
1999: David C Steffens; Christopher M O'Connor; W J Jiang; Carl F Pieper; Maragatha Kuchibhatla; RM Arias; A Look; C Davenport; M B Gonzalez; K Ranga Rama Krishnan
The effect of major depression on functional status in patients with coronary artery disease.
Journal of the American Geriatrics Society 1999;47(3):319-22.
1999: Marcus E McKenzie; A Pothula; Paul A Gurbel; Sergey Y Fuzaylov; Christopher M O'Connor; Wendy A Gattis; Victor L Serebruany
Failure of thrombin generation markers to triage patients presenting with chest pain.
Cardiology 1999;92(1):53-8.
1999: MC Thel; Christopher M O'Connor
Cardiopulmonary resuscitation: historical perspective to recent investigations.
American heart journal 1999;137(1):39-48.
1998: Christopher M O'Connor; P E Carson; Alan B Miller; Milton L Pressler; Robert N Belkin; Gerald W Neuberg; David J Frid; Anne B Cropp; S Anderson; John H Wertheimer; D L DeMets
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation.
The American journal of cardiology 1998;82(7):881-7.
1998: John R Guyton; AC Goldberg; R A Kreisberg; D L Sprecher; HR Superko; Christopher M O'Connor
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia.
The American journal of cardiology 1998;82(6):737-43.
1998: Victor L Serebruany; Raymond D Bahr; Christopher M O'Connor; D R Lowry; Paul A Gurbel
Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet Substudy.
Cardiology 1998;90(1):37-42.
1998: Wendy A Gattis; R L Larsen; Vic Hasselblad; Bradley A Bart; Christopher M O'Connor
Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?
American heart journal 1998;136(1):43-8.
1998: Victor L Serebruany; D Atar; MR Dalesandro; Christopher M O'Connor; Paul A Gurbel
Changes in hemostasis after parenteral magnesium in myocardial ischemia-reperfusion: from animal studies to clinical trials.
Magnesium research : official organ of the International Society for the Development of Research on Magnesium 1998;11(2):133-40.
1998: Christopher M O'Connor; Wendy A Gattis; Karl Swedberg
Current and novel pharmacologic approaches in advanced heart failure.
American heart journal 1998;135(6 Pt 2 Su):S249-63.
1997: MC Thel; A L Armstrong; S E McNulty; Robert M Califf; Christopher M O'Connor
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.
Lancet 1997;350(9087):1272-6.
1997: Bradley A Bart; Linda K Shaw; Charles B McCants; D F Fortin; Kerry L Lee; Robert M Califf; Christopher M O'Connor
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.
Journal of the American College of Cardiology 1997;30(4):1002-8.
1997: W Jiang; W R Hathaway; S McNulty; R L Larsen; K L Hansley; Y Zhang; Christopher M O'Connor
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure.
The American journal of cardiology 1997;80(6):808-11.
1997: Christopher M O'Connor; W R Hathaway; Eric R Bates; J D Leimberger; Kristina N Sigmon; Dean J Kereiakes; BS George; J K Samaha; C W Abbottsmith; R J Candela; Eric J Topol; Robert M Califf
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.
American heart journal 1997;133(6):663-73.
1997: Elizabeth C D Gullette; James A Blumenthal; Michael A Babyak; Wei Jiang; Robert A Waugh; DJ Frid; Christopher M O'Connor; James J Morris; D S Krantz
Effects of mental stress on myocardial ischemia during daily life.
JAMA : the journal of the American Medical Association 1997;277(19):1521-6.
1997: Bradley A Bart; Wendy A Gattis; S J Diem; Christopher M O'Connor
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction.
The American journal of cardiology 1997;79(8):1118-20.
1996: Milton Packer; Christopher M O'Connor; Jalal K Ghali; Milton L Pressler; P E Carson; R N Belkin; Alan B Miller; G W Neuberg; D Frid; J H Wertheimer; Anne B Cropp; D L DeMets
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
The New England journal of medicine 1996;335(15):1107-14.
1996: John C Barefoot; Michael J Helms; D B Mark; James A Blumenthal; Robert M Califf; Thomas L Haney; Christopher M O'Connor; Ilene Siegler; Redford B Williams
Depression and long-term mortality risk in patients with coronary artery disease.
The American journal of cardiology 1996;78(6):613-7.
1996: Wei Jiang; Michael A Babyak; D S Krantz; Robert A Waugh; R Edward Coleman; M M Hanson; D J Frid; S McNulty; J J Morris; Christopher M O'Connor; James A Blumenthal
Mental stress--induced myocardial ischemia and cardiac events.
JAMA : the journal of the American Medical Association 1996;275(21):1651-6.
1996: Christopher M O'Connor; R B Meese; S McNulty; K D Lucas; R J Carney; R M LeBoeuf; W Maddox; C F Bethea; N Shadoff; T F Trahey; J A Heinsimer; J M Burks; G O'Donnell; Mitchell W Krucoff; Robert M Califf
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators.
The American journal of cardiology 1996;77(10):791-7.
1996: Kenneth W Mahaffey; Christopher B Granger; R Collins; Christopher M O'Connor; Erik Ohman; S D Bleich; J J Col; Robert M Califf
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
The American journal of cardiology 1996;77(8):551-6.
1995: M C Thel; Christopher M O'Connor
Magnesium in acute myocardial infarction.
Coronary artery disease 1995;6(10):831-7.
1995: Wei Jiang; James A Blumenthal; Michael W Hanson; R Edward Coleman; Christopher M O'Connor; D Frid; J J Morris; Robert A Waugh
Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring.
The American journal of cardiology 1995;76(5):350-4.
1995: P T Campbell; J S Li; T C Wall; Christopher M O'Connor; P Van Trigt; Richard Kenney; O Melhus; G Ralph Corey
Cytomegalovirus pericarditis: a case series and review of the literature.
The American journal of the medical sciences 1995;309(4):229-34.
1994: Christopher M O'Connor; R Meese; R Carney; J Smith; E Conn; J Burks; C Hartman; S Roark; N Shadoff; M Heard
A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1.
Journal of the American College of Cardiology 1994;23(1):11-8.
1993: P Van Trigt; J Douglas; P K Smith; P T Campbell; T C Wall; Richard Kenney; Christopher M O'Connor; K H Sheikh; G Ralph Corey
A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report.
Annals of surgery 1993;218(6):777-82.
1993: Richard Kenney; J S Li; W A Clyde; T C Wall; Christopher M O'Connor; P T Campbell; P Van Trigt; G Ralph Corey
Mycoplasmal pericarditis: evidence of invasive disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17 Suppl 1():S58-62.
1993: G Ralph Corey; P T Campbell; P Van Trigt; Richard Kenney; Christopher M O'Connor; K H Sheikh; J A Kisslo; T C Wall
Etiology of large pericardial effusions.
The American journal of medicine 1993;95(2):209-13.
1993: Mitchell W Krucoff; M A Croll; James E Pope; Christopher B Granger; Christopher M O'Connor; Kristina N Sigmon; BL Wagner; J A Ryan; Kerry L Lee; Dean J Kereiakes
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion.
Circulation 1993;88(2):437-46.
1992: T C Wall; P T Campbell; Christopher M O'Connor; P Van Trigt; Richard Kenney; K H Sheikh; J A Kisslo; G Ralph Corey
Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade.
The American journal of cardiology 1992;69(12):1075-8.
1992: P T Campbell; P Van Trigt; T C Wall; Richard Kenney; Christopher M O'Connor; K H Sheikh; J A Kisslo; M E Baker; G Ralph Corey
Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy.
Chest 1992;101(4):938-43.
1990: Christopher M O'Connor; Robert M Califf; E W Massey; D B Mark; Dean J Kereiakes; R J Candela; Charles W Abbottsmith; B George; Richard S Stack; L Aronson
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.
Journal of the American College of Cardiology 1990;16(3):533-40.
1988: D B Mark; Mark A Hlatky; Christopher M O'Connor; D B Pryor; T C Wall; M B Honan; Harry R Phillips; Robert M Califf
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues.
Journal of the American College of Cardiology 1988;12(6 Suppl A):32A-43A.
1988: Richard S Stack; Christopher M O'Connor; D B Mark; Tom Hinohara; Harry R Phillips; M M Lee; N M Ramirez; W G O'Callaghan; C A Simonton; E B Carlson
Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.
Circulation 1988;77(1):151-61.